Search

everythinglearnresearchcommunity

for

Search:↓

A baby boy with 13q deletion syndrome had eye cancer, a woman's vision improved after stopping a breast cancer drug, a man developed cataracts from using Propecia, and a rare skin disorder called Lipoid Proteinosis was discussed. Also, a tool called OCT is useful for diagnosing macular diseases.

The document discusses various eye conditions and their treatments, including a rare eye cancer in a baby, vision loss from a cancer drug, cataracts from a baldness treatment, a rare skin disorder, and a specific type of eye disease diagnosed with a special imaging technique.

Finasteride, often used for hair loss, can potentially cause cataracts.

A young woman had a rare, aggressive ovarian tumor that was hard to diagnose and treat, leading to disease progression despite treatment.

Many adult women experience unexplained excessive hair shedding, often starting before age 40.

The document concludes that fexofenadine reduces inflammation in chronic hives, cholestyramine helps half of pregnant women with itchy rashes, and relaxing incisions are a good alternative in facial surgery for the elderly.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

Some chemotherapy can cause permanent hair loss.

Vesiculobullous lesions should be considered part of canine cutaneous epitheliotropic T-cell lymphoma.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

T cells and bacteria in the gut and skin help maintain health and protect against disease.

The document is a detailed medical reference on skin and genetic disorders.

A man developed skin issues from cancer medication, which improved with specific treatments.

Interleukin-2 treatment improved hair growth, sexual function, and reduced fungal infection in a patient with thymoma-related symptoms.

A 24-year-old woman had a rare ovarian tumor that caused male-pattern hair growth and was hard to diagnose and treat.

The document provides a comprehensive index of medical and surgical topics, including hair removal, hair restoration, and various treatments for injuries and conditions.

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.

Skin has specialized touch receptors that can tell different sensations apart.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

The tattoo machine method safely delivers an average of 1,175 µg/cm² of medication into the skin.

Hair follicles are essential for skin health, aiding in hair growth, wound healing, and immune function.

Taking Propecia might lead to the development of cataracts.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Taking 5-Alpha Reductase Inhibitors before bladder removal surgery might make high-grade bladder tumors less aggressive.

The new SIS-PEG sponge is a promising material for skin regeneration and hair growth.

The document concludes that careful diagnosis is crucial for chromosome 13q deletion syndrome, tamoxifen can cause reversible eye damage, finasteride may be linked to cataracts, and OCT is useful for diagnosing macular diseases.

Multiple eye conditions were studied, highlighting the importance of various imaging methods for diagnosis, the vision side effects of drugs tamoxifen and Propecia, and the usefulness of optical coherence tomography for diagnosing and monitoring macular and retinal diseases.

The document concluded that various dermatological treatments have different effectiveness and side effects, with some causing irritation, allergic reactions, or systemic effects.

The model and estimator can predict drug exposure in kidney transplant patients well.